Novel marine metalloprotease-new approaches for inhibition of biofilm formation of Stenotrophomonas maltophilia
- PMID: 37755512
- PMCID: PMC10638167
- DOI: 10.1007/s00253-023-12781-0
Novel marine metalloprotease-new approaches for inhibition of biofilm formation of Stenotrophomonas maltophilia
Abstract
Many marine organisms produce bioactive molecules with unique characteristics to survive in their ecological niches. These enzymes can be applied in biotechnological processes and in the medical sector to replace aggressive chemicals that are harmful to the environment. Especially in the human health sector, there is a need for new approaches to fight against pathogens like Stenotrophomonas maltophilia which forms thick biofilms on artificial joints or catheters and causes serious diseases. Our approach was to use enrichment cultures of five marine resources that underwent sequence-based screenings in combination with deep omics analyses in order to identify enzymes with antibiofilm characteristics. Especially the supernatant of the enrichment culture of a stony coral caused a 40% reduction of S. maltophilia biofilm formation. In the presence of the supernatant, our transcriptome dataset showed a clear stress response (upregulation of transcripts for metal resistance, antitoxins, transporter, and iron acquisition) to the treatment. Further investigation of the enrichment culture metagenome and proteome indicated a series of potential antimicrobial enzymes. We found an impressive group of metalloproteases in the proteome of the supernatant that is responsible for the detected anti-biofilm effect against S. maltophilia. KEY POINTS: • Omics-based discovery of novel marine-derived antimicrobials for human health management by inhibition of S. maltophilia • Up to 40% reduction of S. maltophilia biofilm formation by the use of marine-derived samples • Metalloprotease candidates prevent biofilm formation of S. maltophilia K279a by up to 20.
Keywords: Antimicrobials; Human health management; Marine habitats; Proteases; Stenotrophomonas maltophilia.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Molecular Insight into Gene Response of Diorcinol- and Rubrolide-Treated Biofilms of the Emerging Pathogen Stenotrophomonas maltophilia.Microbiol Spectr. 2022 Jun 29;10(3):e0258221. doi: 10.1128/spectrum.02582-21. Epub 2022 Apr 26. Microbiol Spectr. 2022. PMID: 35471093 Free PMC article.
-
Effect of antimicrobials on Stenotrophomonas maltophilia biofilm.Future Microbiol. 2021 Jan;16(2):83-93. doi: 10.2217/fmb-2020-0115. Epub 2021 Jan 20. Future Microbiol. 2021. PMID: 33470844
-
The rpf/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and β-lactamase induction.FEMS Microbiol Lett. 2019 Mar 1;366(6):fnz069. doi: 10.1093/femsle/fnz069. FEMS Microbiol Lett. 2019. PMID: 31044250
-
Stenotrophomonas maltophilia biofilm: its role in infectious diseases.Expert Rev Anti Infect Ther. 2019 Nov;17(11):877-893. doi: 10.1080/14787210.2019.1685875. Epub 2019 Nov 1. Expert Rev Anti Infect Ther. 2019. PMID: 31658838 Review.
-
A guide to Stenotrophomonas maltophilia virulence capabilities, as we currently understand them.Front Cell Infect Microbiol. 2024 Jan 11;13:1322853. doi: 10.3389/fcimb.2023.1322853. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38274738 Free PMC article. Review.
Cited by
-
Anti-Biofilm Extracts and Molecules from the Marine Environment.Mar Drugs. 2024 Jul 10;22(7):313. doi: 10.3390/md22070313. Mar Drugs. 2024. PMID: 39057422 Free PMC article. Review.
-
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis.Antibiotics (Basel). 2024 Jan 11;13(1):71. doi: 10.3390/antibiotics13010071. Antibiotics (Basel). 2024. PMID: 38247630 Free PMC article. Review.
-
Purification and Properties of a Plasmin-like Marine Protease from Clamworm (Perinereis aibuhitensis).Mar Drugs. 2024 Jan 27;22(2):68. doi: 10.3390/md22020068. Mar Drugs. 2024. PMID: 38393039 Free PMC article.
References
-
- Abda EM, Krysciak D, Krohn-Molt I, Mamat U, Schmeisser C, Forstner KU, Schaible UE, Kohl TA, Nieman S, Streit WR. Phenotypic heterogeneity affects Stenotrophomonas maltophilia K279a colony morphotypes and beta-lactamase expression. Front Microbiol. 2015;6:1373. doi: 10.3389/fmicb.2015.01373. - DOI - PMC - PubMed
-
- Abfalter CM, Schönauer E, Ponnuraj K, Huemer M, Gadermaier G, Regl C, Briza P, Ferreira F, Huber CG, Brandstetter H, Posselt G, Wessler S. Cloning, purification and characterization of the collagenase ColA expressed by Bacillus cereus ATCC 14579. PLoS ONE. 2016;11:e0162433. doi: 10.1371/journal.pone.0162433. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources